FDA Clearance Tracker · P990086
HEALTHTRONICS OSSATRON
Last checked: Nov 19, 2026Latest source record: Oct 12, 2000 (this decision)Source: openFDAMethods & limitations
Decided
Oct 12, 2000
Approval withdrawn
Time to decision
287 days
Received Dec 30, 1999. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P990086
- Device name
- HEALTHTRONICS OSSATRON
- Applicant
- Sanuwave, Inc.
- Applicant location
- Alpharetta, GA
- Received
- Dec 30, 1999
- Decided
- Oct 12, 2000
- Decision
- Approval withdrawn
- Supplements
- 4 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Generator, shock-wave, for pain relief (NBN)
- Device class
- Class III
- Specialty
- Orthopedic Surgery
FDA's approval statement
As written in FDA's record.
THIS DEVICE IS INDICATED FOR USE FOR PERFORMING EXTRACORPOREAL SHOCK WAVE TREATMENT IN PATIENTS WITH CHRONIC PROXIMAL PLANTAR FASCIITIS THAT HAS FAILED TO RESPOND TO CONSERVATIVE TREATMENT. CHRONIC PROXIMAL PLANTAR FASCIITIS IS DEFINED AS PAIN IN THE AREA OF THE INSERTION OF THE PLANTAR FASCIA ON THE MEDIAL CALCANEAL TUBEROSITY THAT HAS PERSISTED FOR SIX MONTHS OR MORE.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code NBN (Generator, shock-wave, for pain relief).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Sanuwave, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- dermaPACE SystemNew device typeDe Novo
DEN160037 · Decided Dec 28, 2017 · 521 days after receipt
Device type: Extracorporeal Shock Wave Device For Treatment Of Diabetic Foot Ulcers (PZL) · General & Plastic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.